Roivant Sciences Newsroom

Roivant Sciences (ROIV) Receives a Buy From Leerink Partners

TipRanksDec 18 13:39

Roivant Sciences Analyst Ratings

BenzingaNov 14 03:01

TD Cowen Maintains Roivant Sciences(ROIV.US) With Buy Rating

Futu NewsNov 13 21:31

H.C. Wainwright Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $18

Futu NewsNov 13 19:32

TD Cowen Maintains Roivant Sciences(ROIV.US) With Buy Rating

Futu NewsNov 13 08:32

Roivant Sciences (ROIV) Receives a Buy From TD Cowen

TipRanksNov 8 21:34

TD Cowen Maintains Roivant Sciences(ROIV.US) With Buy Rating

Futu NewsNov 8 21:32

Leerink Partners Maintains Roivant Sciences(ROIV.US) With Buy Rating

Futu NewsOct 21 20:31

Goldman Sachs Maintains Roivant Sciences(ROIV.US) With Buy Rating

Futu NewsSep 19 20:33

Strong Buy Rating for Roivant Sciences Backed by Strategic Dermavant Divestiture and Promising Clinical Pipeline

TipRanksSep 19 20:27

H.C. Wainwright Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $18

Futu NewsSep 19 18:33

Analysts Offer Insights on Healthcare Companies: Progyny (PGNY) and Roivant Sciences (ROIV)

TipRanksSep 19 18:25

Roivant Sciences Analyst Ratings

BenzingaSep 19 18:22

HC Wainwright & Co. Reiterates Buy on Roivant Sciences, Maintains $18 Price Target

BenzingaSep 19 18:22

TD Cowen Maintains Roivant Sciences(ROIV.US) With Buy Rating

Futu NewsSep 19 06:32

Jefferies Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $18

Futu NewsSep 16 20:31

BofA Securities Maintains Roivant Sciences(ROIV.US) With Hold Rating, Maintains Target Price $12.5

Futu NewsSep 11 21:31

TD Cowen Maintains Roivant Sciences(ROIV.US) With Buy Rating

Futu NewsSep 11 21:31

B of A Securities Maintains Neutral on Roivant Sciences, Raises Price Target to $12.5

BenzingaSep 11 21:14

A Quick Look at Today's Ratings for Roivant Sciences(ROIV.US), With a Forecast Between $12.5 to $18

Futu NewsSep 11 21:00